Compositions and methods of administering baclofen
US11523984B1 · kind B1 · utility
0Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2021 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | Nov 12, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Injectable baclofen formulations and methods that are bioequivalent in terms of plasma baclofen exposure to oral dosage forms but with reduced exposure ratios of baclofen to the M1 metabolite.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.